In one paragraphArticle in bioRxiv : the preprint server for biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
10 authors.
Hung N DoTheoretical Biology and Biophysics Group, Theoretical Division, Los Alamos National Laboratory, Los Alamos, NM, USA 87545.ORCID 0000-0002-6497-4096 Daniel P LeamanDepartment of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA 92037, USA.ORCID 0000-0002-8490-1126 Pooja Ralli-JainDepartment of Laboratory Medicine & Pathology, University of Washington School of Medicine, Seattle, Washington 98195, USA.
Cynthia A DerdeynDepartment of Laboratory Medicine & Pathology, University of Washington School of Medicine, Seattle, Washington 98195, USA.ORCID 0000-0002-1220-513X Michael B ZwickDepartment of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA 92037, USA.ORCID 0000-0002-0885-2502 S GnanakaranTheoretical Biology and Biophysics Group, Theoretical Division, Los Alamos National Laboratory, Los Alamos, NM, USA 87545.ORCID 0000-0002-9368-3044 Funding
Project 3 - Dynamics of latent HIV-1 reservoirs: High resolution antigenic mapping and strategies to block reboundU54AI170752 · NIAID · DUKE UNIVERSITY · PI Priyamvada Acharya · 2022 to 2026
$32.0MStructural and dynamic traits underlying phenotypic variation in HIV-1 EnvR01AI140868 · NIAID · UNIVERSITY OF WASHINGTON · PI Kelly Keisen Lee · 2019 to 2026
$5.3MInterplay of the HIV-1 Env cytoplasmic tail, Gag-MA, and membrane: resolving molecular detail and blocking assemblyR01AI179697 · NIAID · UNIVERSITY OF WASHINGTON · PI DERDEYN, CYNTHIA ANN, GNANAKARAN, SANDRASEGARAM · 2023 to 2025
$3.1MExploiting glycan holes and sequence diversity of naturally occurring HIV envelope towards the design of vaccine immunogen panels for induction of neutralization breadthR01AI186650 · NIAID · UNIVERSITY OF WASHINGTON · PI Cynthia Ann Derdeyn, Sandrasegaram Gnanakaran · 2024 to 2026
$2.3MGates Foundation INV-010646NIAID NIH HHS R01 AI140868NIAID NIH HHS R01 AI179697NIAID NIH HHS R01 AI186650NIAID NIH HHS U54 AI170752
6 · The paper itselfAbstract
The envelope surface glycoprotein (Env) on HIV-1 drives cell entry and genome delivery through its receptor binding and membrane fusion activities. Incorporation of Env onto assembling virions is governed by its cytoplasmic tail (Env-CT) and the matrix (MA) domain of the PR55
Indexed as
cryo-electron tomographycytoplasmic tailEnvGagglycoproteinHIV-1matrix proteinmaturationmembranemolecular dynamicsprotein dynamicsretrovirussubtomogram averagingvirus structure
Identifiers
PMID41648420
PMCPMC12871272
What OpenQuestion holds
Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390